We recently compiled a list of the 12 Top Performing Consumer Staples Stocks in February. Kenvue Inc. (NYSE:KVUE) is one of the best performing stocks.

TheFly reported on March 6 that Barclays increased its price target for KVUE to $19 from $18 while maintaining an Equal Weight rating on the stock. This revision followed updates to the company model after the Q4 report.

In a different legal incident, on February 26, a Panola County, Texas, judge rejected Kenvue Inc. (NYSE:KVUE)'s request to have a lawsuit filed by the state’s attorney general, Ken Paxton, dismissed. According to the lawsuit, Kenvue misrepresented Tylenol by neglecting to mention possible hazards for children when pregnant women take the medication, including connections to autism and other developmental issues.

The company’s motion was denied by the judge in a succinct, one-sentence order; the specific justification for the ruling has not yet been disclosed. This decision upholds the allegations against KVUE involving the marketing and safety disclosures of its Tylenol products and permits the case to continue in Texas courts.

Legal observers point out that the ruling highlights continued scrutiny of drug labeling and public health protections for pregnant women and children, as well as the courts’ willingness to permit cases alleging consumer harm from pharmaceutical products to proceed, even when companies seek early dismissal. The result may have an impact on KVUE’s larger risk and liability management plans in the US pharmaceutical industry.

Kenvue Inc. (NYSE:KVUE) is a consumer health company that develops and markets personal care and wellness products, including leading brands in skin care, baby care, and over‑the‑counter health categories.

While we acknowledge the potential of KVUE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.